Brighter receives 10 MSEK from directed share issue.
The pricing period in the first of the two directed new issues of SEK 10 million each, announced on March 4, 2019, is over. Brighter has received SEK 10 million. The price per share was set at SEK 8.31 in accordance with the communicated terms. The number of new shares issued to the investor Knight Capital Limited is 1,203,369 and the total number of shares after the transaction amounts to 76,209,813.
Brighter has, in line with the agreement, called for the additional SEK 10 million. The share price for the optional issue shall be established by the VWAP of the Brighter share during the period of March 21st to April 1st with an 8% discount.
For further information, please contact:
Truls Sjöstedt, CEO
Phone: +46 709 73 46 00
Ann Zetterberg, CFO
Phone: +46 708 37 21 23
About Brighter AB (publ)
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop® - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. https://brighter.se/
The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, email@example.com, www.eminova.se.
This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 11:00 CET on March 25, 2019.